Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murata, G.
Right arrow Articles by Halperin, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Murata, G.
Right arrow Articles by Halperin, A.

Chest, Vol 98, 845-849, Copyright © 1990 by American College of Chest Physicians

ARTICLES

Intravenous and oral corticosteroids for the prevention of relapse after treatment of decompensated COPD. Effect on patients with a history of multiple relapses

GH Murata, MS Gorby, TW Chick and AK Halperin
Ambulatory Care Service, Veterans Affairs Medical Center, Albuquerque 87111.

To determine if a regimen of intravenous and oral corticosteroids reduces the relapse rate after treatment of decompensated COPD in the ED, 30 patients were studied. Forty-five visits in which intravenous and oral corticosteroids were given (T visits) were compared with an equal number of matched visits in which they were withheld (N visits). No differences were noted between T and N visits with respect to clinical findings, laboratory results and other forms of therapy. Treatment with corticosteroids reduced the relapse rate within 24 h of discharge. At 48 h, the cumulative relapse rate for T visits (8.9 percent) was significantly lower than for N visits (33.3 percent; p = 0.005). For patients with a history of multiple relapses, a regimen consisting of intravenous and oral corticosteroids reduces the risk of relapse after ED treatment of decompensated COPD.


This article has been cited by other articles:


Home page
 Postgrad. Med. J.Home page
J R Hurst and J A Wedzicha
Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation
Postgrad. Med. J., September 1, 2004; 80(947): 497 - 505.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
J. A. Wedzicha
Role of Viruses in Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2004; 1(2): 115 - 120.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
W. Willaert, M. Daenen, P. Bomans, G. Verleden, and M. Decramer
What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations?
Eur. Respir. J., May 1, 2002; 19(5): 928 - 935.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. A. Wedzicha
Exacerbations* : Etiology and Pathophysiologic Mechanisms
Chest, May 1, 2002; 121(5_suppl): 136S - 141S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. A. R. SEEMUNGAL, G. C. DONALDSON, A. BHOWMIK, D. J. JEFFRIES, and J. A. WEDZICHA
Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1608 - 1613.
[Abstract] [Full Text]

Home page
 NEJMHome page
G. T. Ferguson and R. M. Cherniack
Management of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., April 8, 1993; 328(14): 1017 - 1022.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American College of Chest Physicians.